[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338458-105":59,"doc-detail-338458-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","genomic-instability-as-a-driver-and-suppressor-of-anti-tumor-immunity","Genomic instability as a driver and suppressor of anti-tumor immunity","","Genomic instability drives and accelerates tumorigenesis while also shaping outcomes across cancer types. Although it is linked to immune evasion and poorer prognosis, accumulating evidence indicates it can trigger pro-inflammatory signaling and increase tumor-cell immunogenicity, improving immune recognition. The paradox likely depends on context, yet mechanistic understanding is critical to raise cancer immunotherapy success. This review outlines molecular links between genomic instability, inflammatory pathways, and immune surveillance, and details how genomically unstable tumors evade immunity.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genomic-instability-as-a-driver-and-suppressor-of-anti-tumor-immunity/338458/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genomic-instability-as-a-driver-and-suppressor-of-anti-tumor-immunity/338458.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"How does genomic instability influence tumorigenesis and disease progression?","Question",{"text":112,"@type":113},"Genomic instability increases genomic alterations that promote malignant transformation and cancer progression. It also fuels tumor evolution by providing genetic diversity and selective advantages under pressure.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why can genomic instability both enhance immune recognition and support immune evasion?",{"text":117,"@type":113},"Genomic instability can activate pro-inflammatory signaling and increase immunogenicity through neoantigen generation, promoting immune surveillance. At the same time, tumors can evolve immune-evasion mechanisms that counteract recognition, leading to context-dependent outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does cGAS-STING signaling play in the link between genomic instability and immunity?",{"text":121,"@type":113},"The review highlights cGAS/STING activation as a primary inflammatory consequence of genomic instability. This pathway supports pro-inflammatory signaling that can enhance immune surveillance and recognition of DNA-damaged cells.",{"name":123,"@type":110,"acceptedAnswer":124},"How do genomically unstable tumors evade immune checkpoint blockade despite pro-inflammatory correlates?",{"text":125,"@type":113},"Even when pro-inflammatory signaling and genetic alterations correlate with checkpoint blockade response, durable response rates in genomically unstable tumors can remain low. The review emphasizes the need to understand specific mechanisms of immune recognition and immune evasion in these tumors to enable more effective complementary strategies.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},338458,1790645749,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":26,"preview_page_count":19,"preview_urls":149},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","TYPE Review  \nPUBLISHED 11 October 2024  \nDOI 10.3389/fimmu.2024.1462496  \nOPEN ACCESS  \nEDITED BY  \nDong Zhang,  \nNew York Institute of Technology, United States  \nREVIEWED BY  \nCansu Cimen Bozkus,  \nIcahn School of Medicine at Mount Sinai, United States  \nEileen Parkes,  \nUniversity of Oxford, United Kingdom Souren Paul,  \nUniversity of Minnesota Twin Cities, United States  \n*CORRESPONDENCE  \nMarco de Bruyn  \n [m.de.bruyn@umcg.nl](m.de.bruyn@umcg.nl)  \nRECEIVED 10 July 2024  \nACCEPTED 23 September 2024  \nPUBLISHED 11 October 2024  \nCITATION  \nRequesens M, Foijer F, Nijman HW and de Bruyn M (2024) Genomic instability  \nas a driver and suppressor of anti-tumor immunity.  \nFront. Immunol. 15:1462496 .  \ndoi: 10.3389/fimmu.2024.1462496  \nCOPYRIGHT  \n© 2024 Requesens, Foijer, Nijman and de Bruyn. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nGenomic instability as adriver and suppressor of anti-tumor immunity  \nMarta Requesens 1, Floris Foijer 2, Hans W. Nijman 1 and Marco de Bruyn 1*  \n1 Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 2 European Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, Groningen, Netherlands  \nGenomic instability is a driver and accelerator of tumorigenesis and inﬂuences disease outcomes across cancer types. Although genomic instability has been associated with immune evasion and worsened disease prognosis, emerging evidence shows that genomic instability instigates pro-inﬂammatory signaling and enhances the immunogenicity of tumor cells, making them more susceptible to immune recognition. While this paradoxical role of genomic instability in cancer is complex and likely context-dependent, understanding it is essential for improving the success rates of cancer immunotherapy. In this review, we provide an overview of the underlying mechanisms that link genomic instability to proinﬂammatory signaling and increased immune surveillance in the context of cancer, as well as discuss how genomically unstable tumors evade the immune system. A better understanding of the molecular crosstalk between genomic instability, inﬂammatory signaling, and immune surveillance could guide the exploitation of immunotherapeutic vulnerabilities in cancer.  \nKEYWORDS  \ngenomic instability, MMRd, chromosomal instability, cGAS-STING, tumor-inﬁltrating lymphocytes, immune evasion  \n1 Introduction  \nGenomic instability, deﬁned as an increased tendency of genomic alterations during subsequent cell divisions, is a hallmark of cancer and plays key roles in malignant transformation, cancer progression, and response to treatment (1, 2) . The accumulation of mutations and genomic alterations can result in the activation of oncogenes, the inactivation of tumor suppressor genes, and the dysregulation of key cellular pathways, ultimately leading to transformation and uncontrolled cell proliferation. Through the acquisition of genetic diversity, genomic instability fuels tumor evolution and endows tumor cells with a survival advantage, enabling them to adapt to changing conditions and upon selective pressure (1, 2) .  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nNevertheless, genomic instability can have detrimental effects on cell viability. In addition to reducing tumor cell ﬁtness through several cell-intrinsic mechanisms, genomic instability triggers a cascade of cell and non-cell autonomous inﬂammatory signaling pathways (3) . This leads to the release of cytokines and chemokinesto att","cbCaihSV570JrLnF","https://ap.wps.com/l/cbCaihSV570JrLnF","pdf",5814141,24,"English","# Introduction\n# Cellular mechanisms of genomic instability in cancer\n## DNA damage checkpoints and downstream signaling\n## Neoantigen generation and immune surveillance\n# Immune evasion in genomically unstable tumors","[{\"question\":\"How does genomic instability influence tumorigenesis and disease progression?\",\"answer\":\"Genomic instability increases genomic alterations that promote malignant transformation and cancer progression. It also fuels tumor evolution by providing genetic diversity and selective advantages under pressure.\"},{\"question\":\"Why can genomic instability both enhance immune recognition and support immune evasion?\",\"answer\":\"Genomic instability can activate pro-inflammatory signaling and increase immunogenicity through neoantigen generation, promoting immune surveillance. At the same time, tumors can evolve immune-evasion mechanisms that counteract recognition, leading to context-dependent outcomes.\"},{\"question\":\"What role does cGAS-STING signaling play in the link between genomic instability and immunity?\",\"answer\":\"The review highlights cGAS/STING activation as a primary inflammatory consequence of genomic instability. This pathway supports pro-inflammatory signaling that can enhance immune surveillance and recognition of DNA-damaged cells.\"},{\"question\":\"How do genomically unstable tumors evade immune checkpoint blockade despite pro-inflammatory correlates?\",\"answer\":\"Even when pro-inflammatory signaling and genetic alterations correlate with checkpoint blockade response, durable response rates in genomically unstable tumors can remain low. The review emphasizes the need to understand specific mechanisms of immune recognition and immune evasion in these tumors to enable more effective complementary strategies.\"}]","Genomic instability as a driver and suppressor of anti-tumor immunity | PDF",1790023710,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f23888f1949ab97fe7bf068c7f591c3.webp",983,1389,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90c45e32e680e9a02f55409351fcb4ef.webp",982,1388,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/899273c3cc50c8306a7fa1d0d2f3b1c0.webp",981,1386,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef61f3cdb623dc5d05aff7159605bc79.webp",980,1385]